Amy Walker Acquires Shares in 4basebio PLC
Amy Walker, an insider at 4basebio PLC (LON:4BB), recently purchased 1,151 shares of the company's stock on February 28th. The shares were acquired at an average price of GBX 1,120, which is approximately $14.12 per share. The total value of this transaction amounted to £12,891.20, equivalent to about $16,250.09.
Recent Trading Activity
In the latest trading session, 4basebio's stock declined by 5.9%, bringing the price down to GBX 1,091 ($13.75). The trading volume was notably low, with only 3 shares exchanged, compared to an average of 827 shares. The current market capitalization of the company stands at £139.76 million. Its price-to-earnings ratio is marked at -1,398.72, while the beta is 1.09, indicating some volatility. Financial ratios reveal a quick ratio of 3.52, a current ratio of 2.73, and a debt-to-equity ratio of 201.47. Over the last 50 days, the stock has had a moving average price of GBX 1,178.90, and over the past 200 days, it averaged GBX 1,280.77. Notably, the shares have reached a 12-month low of GBX 821 ($10.35) and a high of GBX 1,820 ($22.94).
About 4basebio
4basebio is a specialist life sciences group dedicated to providing therapeutic synthetic DNA for use in gene therapies and gene-based vaccines. The company is committed to developing high-quality, GMP-grade synthetic DNA, as well as non-viral nanoparticles designed for the effective and safe delivery of DNA/RNA-based products to patients.
Investment Considerations
If you are contemplating an investment in 4basebio, it is essential to weigh your options carefully. Currently, analysts have rated the stock as a Hold, indicating that there might be more attractive investment opportunities in the market. In fact, several top-rated analysts have identified various stocks that are gaining attention and are seen as better options at this time.
In conclusion, Amy Walker's recent purchase of shares reflects confidence in the company's future, although potential investors should conduct thorough research and consider broader market indicators before making decisions.
investment, stocks, 4basebio